If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com). The website is updated approximately twice a month.
PDP Press Releases/ statements
• 23 Oct: Dedication, not defeat
• 23 Oct: ‘Of all the moments for science to slow down, this is not it.’
• 30 Oct: IAVI calls for innovative partnerships to sustain vaccine development at the World Vaccine Congress Europe 2025
• 10 Nov: Vector control has prevented over 1 billion malaria cases in Africa since 2000, new analysis reveals
• 13 Nov: WHO Report Shows TB Gains, But Funding Gaps Threaten Momentum
• 18 Aug: Japan commits new funding to develop treatments for drug-resistant infections
• 23 Oct: PATH joins WHO’s Global Clinical Trials Forum
• 12 Nov: MMV announced as an Action for Women’s Health awardee
• 12 Nov: Phase 3 trial for next-generation malaria treatment GanLum meets primary endpoint, with potential to combat antimalarial resistance
• 13 Oct: MMV joins WHO-led Global Clinical Trials Forum as part of its commitment to equitable and inclusive research
• 27 Oct: In memory of Professor Jean Louis Abdourahim Ndiaye
• 4 Nov: European Commission invests EUR 20 million to develop urgently-needed medicines against dengue in partnership with AFD and DNDi
• 11 Sep: FIND announces appointment of Dr Jutta Reinhard-Rupp as Chief Scientific Officer
• 12 Sep: FIND appoints Henri Mwaniki as Chief Financial Officer
• 13 Oct: IVI joins WHO’s new Global Clinical Trials Forum
• 14 Aug: EVI begins clinical trial for promising malaria vaccine in Burkina Faso
MDGH
PDP Funder News/Announcements
• 3 Oct: The Global Fund works—these stories remind us why it’s essential. Gates Foundation
• 5 Oct: Advancing new and underused innovations to end preventable death in childbirth. Unitaid
• 17 Oct: Ambassador Anne Claire Amprou appointed new Chair of Unitaid’s Executive Board. Unitaid
• 23 Oct: Unitaid to improve access to diagnostics through integrated tools and delivery approaches with new call for proposals. Unitaid
Funder Announcement Archives
• 2014 PDP Funder Announcements
• 2013 PDP Funder Announcements
New PDP Publications
• 25 Apr: Rethinking antibodies for infectious diseases?. IAVI
Other Reports/ Publications
• 4 Nov: More From Less: Optimising Vaccines in a Constrained World. CGD
• 10 Nov: Report: State of disunion: The impact of US funding cuts on global health R&D. Impact for Global Health
• 10 Nov: Pipeline Report: 2025 Tuberculosis Diagnostics. TAG
• 9 Oct: 2026 Index Methodology zeroes in on scalable actions capable of delivering lasting impact for more people. Access to Medicines Foundation
• Oct: Forecasting global demand for novel TB vaccines: scenarios for early planning and needs assessment. Gavi & CHAI
• 13 Oct: No eradication without innovation: the EU at a crossroads to eliminate HIV/AIDS, TB, and malaria. Global Health Advocates
• 20 Oct: THE PRICE OF RETREAT How underinvestment in malaria risks resurgence, lost growth, and a generation’s future. ALMA et al.
Related Press Releases/ Announcements/Articles
• 1 Nov: A global health expert on Covid’s lessons — and warnings — for the future. STAT
• 2 Oct: WHO releases new reports on new tests and treatments in development for bacterial infections. WHO
• 2 Oct: Analysis of antibacterial agents in clinical and preclinical development: overview and analysis 2025. WHO
• 2 Oct: Broader access urged for affordable HIV drug. SciDevNet
• 2 Oct: Babies' deaths in Cameroon show how US aid cuts curtail malaria fight. Reuters
• 2 Oct: New study shows all-in-one coronavirus vaccines could save millions of lives in future pandemics. CEPI
• 3 Nov: EIB signs a Guarantee Agreement with MedAccess to boost access to essential medical supplies in Africa. EIB
• 3 Nov: From Warp Speed to COVAX: An insider’s story. Politico
• 3 Nov: WHO issues guidance to address drastic global health financing cuts. WHO
• 3 Nov: Faulty field test undermines fight against malaria, says new research. The Telegraph
• 3 Nov: Trial data highlight sustained protection from dengue vaccine. CIDRAP
• 4 Nov: WHO and Bayer AG renew longstanding collaboration to eliminate three deadly neglected tropical diseases. WHO
• 4 Nov: Global perspectives on infectious diseases at risk of escalation and their drivers. Nature
• 4 Nov: G20 2025: advancing equity and affordability in future tuberculosis vaccines for adolescents and adults. The Lancet Infectious Diseases
• 4 Nov: Every pound of UK aid put into disease control guards against one of the most dangerous enemies of our time. The Independent
• 4 Nov: More From Less: Optimising Vaccines in a Constrained World. CGD
• 4 Nov: In rural Malawi, malaria might have wings but the malaria vaccine rides a bike. Gavi
• 4 Nov: Faulty malaria rapid test raises global concerns, say MORU researchers. Centre for Tropical Medicine & Global Health
• 4 Nov: Countries Criticise ‘Inadequate’ Pathogen-Sharing Draft Annex at Start of Text-Based Talks. Health Policy Watch
• 4 Nov: Smarter Vaccine Doses: A High-Impact Fix for Global Immunization. CGD
• 4 Nov: Withdrawal of US aid has hurt South Africa’s HIV programme. Spotlight
• 5 Nov: America has turned its back on science. Could the UK save the world?. The New World
• 5 Nov: Lenacapavir Regulatory Approval. AVAC
• 6 Nov: Navigating change to shape the future of global health research. NIHR
• 6 Nov: WHO publishes new global research agenda to strengthen paediatric clinical trials. WHO
• 6 Nov: Untangling choices: how awareness and socio-economic status shape malaria vaccination decisions among Ghanaian women. Malaria Journal
• 6 Nov: New Portable Test Detects Asymptomatic Malaria in 45 Minutes. Medscape
• 6 Nov: Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Malawi. The Lancet
• 6 Nov: WHO voices concerns about equitable access to novel TB vaccines. CIDRAP
• 6 Nov: Biovac opens new vaccine lab in Cape Town to boost Africa's manufacturing capacity. Reuters
• 6 Nov: AI steps in to detect the world's deadliest infectious disease. NPR
• 6 Nov: Questions for the America First Global Health Strategy. Think Global Health
• 6 Oct: The AMR Panel Playbook: Eight Lessons for Building an Independent Panel on Antimicrobial Resistance. CGD
• 7 Nov: B cells targeting parasites capture spatially linked antigens to secure T cell help. Science
• 7 Nov: American Barter: Aid In Exchange for Information on Pathogen. Geneva Health Files
• 7 Nov: "Relief" for mothers in Bayelsa state as malaria vaccine makes waves. Gavi
• 7 Nov: ‘Africa could be at a turning point in the fight against malaria’. Channel Africa
• 7 Nov: New study evaluates accuracy of rapid diagnostic tests for malaria. Centre for Tropical Medicine & Global Health
• 7 Nov: 'Needle in a haystack' experiments reveal targets for new tuberculosis vaccines. Fierce Biotech
• 7 Nov: US template for bilateral health deals bypasses WHO pandemic negotiations. Devex
• 7 Nov: Bilateral deals would undermine pandemic preparedness, multilateralism is the only answer. The Independent Panel
• 7 Nov: State Department Plans New Framework to Advance America First Global Health Strategy. Bloomberg
• 7 Nov: UK set to slash aid funding to fight deadly diseases – putting 250,000 lives at risk. The Independent
• 7 Oct: Babies take a lesson from soldiers in the war against malaria. NPR
• 8 Nov: Budget's $2.7B cut to foreign aid leaves international development in limbo, say NGOs. CBC
• 8 Nov: US to demand countries share data on ‘pathogens with epidemic potential’ in return for health aid. The Guardian
• 8 Oct: The path from early- to late-liver stage arresting genetically attenuated parasites as a malaria vaccination strategy. Nature Vaccines
• 8 Oct: Safety and pharmacokinetics of dolutegravir dispersible tablets and oral films in term neonates exposed to HIV in South Africa (PETITE-DTG study): an open-label, randomised, phase 1/2 trial. The Lancet HIV
• 8 Oct: Dolutegravir in neonates: finally we are getting there!. The Lancet HIV
• 8 Oct: Stronger, faster, fairer: making mpox vaccines accessible. CEPI
• 8 Oct: Randomized Trial of Targeted Indoor Spraying to Prevent Aedes-Borne Diseases. NEJM
• 8 Oct: ‘Bluetoothing’: Blood-Sharing Drug Trend Fuels Alarming Global H.I.V. Surge. The New York Times
• 8 Oct: UK launches new aid inquiry in response to 40% budget cut. Devex
• 9 Oct: Africa must lead its own health research revolution. SciDevNet
• 9 Oct: The impact of cuts in the US President's Emergency Plan for AIDS Relief funding for HIV pre-exposure prophylaxis in sub-Saharan Africa: a modelling study. Lancet HIV
• 9 Oct: Elucidated protein structures in the malaria parasite offer opportunities for new vaccines. MedicalXpress
• 9 Oct: Pharma’s shift away from infectious disease research could spell disaster for the world’s poorest people. STAT
• 9 Nov: New Tanzanian Malaria vaccine shows strong immune response in early trials. The Citizen
• 9 Oct: The six-monthly anti-HIV jab is coming. But can SA keep track of millions of users?. BHEKISISA
• 9 Oct: US aid cuts are being felt across Africa. Here’s where.. The Washington Post
• 9 Oct: Ebola vaccine safe for mothers and infants. Nature
• 9 Oct: China joining COVAX boosts bid to ensure fair access to vaccine - GAVI tells Reuters. Reuters
• 10 Nov: How the mpox vaccine has changed lives – and minds – in Kinshasa. Gavi
• 11 Nov: African Countries Affirm Support for Multilateral Pandemic Agreement Amid Pressure to Make Bilateral Deals with US. Health Policy Watch
• 11 Nov: Public awareness and acceptance of malaria vaccine in Sub-Saharan Africa: a systematic review. BMC
• 11 Nov: In real-world study, malaria vaccine effectiveness matches clinical trials. CIDRAP
• 11 Nov: UK cuts contribution to Aids, tuberculosis and malaria fund by £150m. The Guardian
• 11 Nov: Preparing for LEN: Learning Lessons, Accelerating Access, Reducing Time to Impact. AVAC
• 12 Nov: Novartis’ new malaria treatment shows promise against resistant parasites. Devex
• 12 Nov: New malaria drug could be a life-saver as the standard drug shows signs of weakness. NPR
• 12 Nov: New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial. Health Policy Watch
• 12 Nov: Are we getting closer to the world’s first Nipah vaccine?. Gavi
• 12 Nov: As Belgium Races to Save U.S.A.I.D. Contraception, Some Supplies Are Reported Ruined. The New York Times
• 12 Nov: Scientific advances collide with major infrastructure upheaval. AVAC
• 12 Nov: Global gains in tuberculosis response endangered by funding challenges. WHO
• 13 Nov: New malaria treatment could fight growing threat of drug resistance. EuroNews
• 13 Nov: US has begun bilateral health negotiations with 16 African nations. Devex
• 13 Oct: Innovation in medicines for global health: a 20-year landscape analysis. Nature Drug Discovery
• 13 Oct: Sharp global rise in antibiotic-resistant infections in hospitals, WHO finds. The Guardian
• 13 Oct: EIB and European Commission join forces with BioNTech to build a sustainable vaccine ecosystem in Africa. Science Business
• 13 Oct: How do recurrent malaria infections occur in clinical cohorts: a mathematical modelling study to support study planning. Malaria Journal
• 13 Oct: Germany commits €1B to Global Fund as aid cuts shape World Health Summit. Devex
• 13 Oct: Foreign Aid Is Mostly Gone. It Could Be Replaced With Something Better. The New York Times
• 13 Oct: Antimicrobial resistance, equity and justice in low- and middle-income countries: an intersectional critical interpretive synthesis. Nature
• 14 Nov: Safety outcomes among infants whose mothers used the dapivirine vaginal ring or oral PrEP during pregnancy (MTN-042/DELIVER): a randomised phase 3b study. The Lancet HIV
• 14 Oct: One in Six Bacterial Infections Is Antibiotic Resistant; Calls for Stronger Real-Time Pandemic Risk Surveillance. Health Policy Watch
• 14 Oct: As new infections outpace new drugs, are we sleepwalking into a global health disaster?’. The Guardian
• 14 Oct: BioNTech's African mRNA vaccine production push gets EU funding boost. Fierce Pharma
• 14 Oct: Novo Nordisk Foundation pledges up to $31M to support AI-powered pandemic preparedness platform. Fierce Biotech
• 14 Oct: Report proposes new framework to prepare for future pandemics. CIDRAP
• 14 Oct: POST introduction evaluation (PIE) of the malaria vaccine introduced in three pilot countries (Ghana, Kenya, and Malawi) in 2021. Malaria Journal
• 14 Oct: Africa imports over 70% of its medicines. Making active ingredients locally would change this. Gavi
• 14 Oct: Serum Institute of India and CEPI supercharge pandemic response preparedness targeting H5N1. CEPI
• 14 Oct: Stop playing catch-up with superbugs: the anticipatory governance of antimicrobial resistance. WEF
• 15 Oct: Forecasting global demand for life-saving TB vaccines. CHAI
• 15 Oct: Antimalarial resistance deserves higher priority in global AMR strategy. Oxford Centre for Tropical Medicine & Global Health
• 15 Oct: Haphazard US CDC staff cuts leave questions around impact. Devex
• 16 Sep: Turning Against Vaccines, America Is a Global Outlier. The New York Times
• 16 Oct: Low-cost vaccine vial monitors damaging heat exposure brought to market. MedicalXpress
• 16 Oct: Chikungunya, spreading fast this year, visits Mombasa for a third time. Gavi
• 16 Oct: The US and Europe have cut billions in health aid — can anyone fill the gap?. Nature
• 16 Oct: Global Health Leaders Urge Fewer Agencies Amid Funding Crisis. Health Policy Watch
• 16 Oct: Machine learning advances drug discovery through generalizable models. News Medical
• 16 Sep: NIH funds new center focused on preventing drug-resistant infections. CIDRAP
• 17 Oct: Drive to include pregnant and breastfeeding women and children in clinical trials. Health Policy Watch
• 17 Oct: New Monoclonal Antibody Shows Promise for Preventing Malaria Infections. Newswise
• 17 Oct: Physicians’ knowledge of, and willingness to encourage caregivers to partake in the RTS S/AS01 and R21 matrix M malaria vaccines roll out – a national survey in Nigeria. BMC Infectious Diseases
• 17 Oct: Africa CDC chief: 60% of foreign health aid was effectively wasted. Devex
• 18 Oct: Preserving clinical skills in the age of AI assistance. The Lancet
• 18 Oct: New monoclonal antibody prevents malaria infection in early clinical trial. MedicalXpress
• 19 Oct: Trump is cutting foreign aid. He’s not the only one. Politico
• 20 Oct: True Diagnostics nabs BARDA award of up to $11M for Ebola, Marburg fingerstick rapid test. 360Dx
• 20 Oct: A simple strategy to cut malaria infection rates in babies. Nature Medicine
• 20 Oct: Can innovative models close financing gaps for neglected disease R&D?. Devex
• 20 Oct: Defunding mRNA vaccine research leaves us all more vulnerable to future health emergencies. BMJ
• 20 Oct: Who should get the first doses of the twice-a-year HIV prevention jab? It could be in 360 clinics by February. Bhekisisa
• 20 Oct: Are Cabotegravir Injections More Tolerable Than Lenacapavir?. POZ
• 20 Oct: Rethinking global health R&D: a system under pressure, time for reform. Impact for Global Health
• 20 Oct: Insights into malaria parasite's sodium pump structure could reshape treatment. Phys.org
• 21 Oct: Caregivers’ practices and factors associated with malaria vaccine uptake among under-five children in the Tiko Health District, Cameroon: A community based cross-sectional study. PLOS Global Health
• 21 Oct: Malaria Resurgence Could Kill Nearly One Million by 2030 as Funding Cuts Hit. Health Policy Watch
• 21 Oct: 7-year Wellcome grant awarded to advance health research and training in Africa. University of Liverpool
• 21 Oct: Anti-malaria funding cuts could lead to ‘deadliest resurgence ever’, study warns. The Guardian
• 21 Oct: Gilead agrees not to raise prices on HIV medicines for state AIDS drug programs. STAT
• 21 Oct: As aid shrinks, top philanthropies test new ways to spur economic growth. Devex
• 21 Oct: ‘I fear we are sitting on a time bomb.’ Scientists debate mass distribution of antibiotics in Africa. Science
• 21 Oct: Moxidectin combination therapies for lymphatic filariasis—36-month follow-up. The Lancet Infectious Diseases
• 22 Oct: A crisis in malaria treatment is coming — we must act faster to contain it. Devex
• 22 Oct: Global progress against neglected tropical diseases continues despite challenges, new WHO report finds. WHO
• 22 Oct: A shot at survival: Zambia prepares to roll out malaria vaccination. Gavi
• 22 Oct: Spatial repellents could help supercharge the fight against malaria. Forbes
• 22 Oct: How did dengue go global? This mosquito species might be to blame. Georgetown University
• 23 Oct: Top African Pharma Executive Bluntly Lists Barriers to Local Manufacturing. Health Policy Watch
• 23 Oct: Africa Seeks More Self-Reliance Amid Disease Outbreaks and Decline in Donor Funds. Health Policy Watch
• 23 Oct: Can Africa’s drug regulators be both fast and trusted?. Devex
• 23 Oct: Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development. Science Direct
• 23 Oct: Inclusion of women who are pregnant, lactating, or of reproductive potential in clinical trials: health, ethical, and regulatory considerations. The Lancet
• 23 Oct: WHO and MPP Launch Phase 2.0 of the mRNA Technology Transfer Programme. Medicines Patent Pool
• 24 Oct: Togo introduces the malaria vaccine: a health milestone. Gavi
• 24 Oct: How HIV research drives health innovation in multiple diseases. Nature
• 24 Oct: WHO Reports 40 Percent Jump in Antibiotic-Resistant infections; BU-Based Nonprofit Leads the Fight Back. Boston University
• 24 Oct: A vaccine visionary reflects: Seth Berkley's global memoir is a shot worth taking. Gavi
• 25 Oct: In Fight Against Malaria, an Unexpected — and Snuggly — Shield. The New York Times
• 25 Oct: Nigeria Launches Project to Prevent Antimalarial Drug Resistance. Voice of Nigeria
• 27 Oct: Private donors gave more than $125M to keep foreign aid programs going after US cuts. AP
• 27 Oct: New Executive Director and CEO to lead NIVI into the next phase of revolutionizing and accelerating vaccine development. NIVI
• 27 Oct: HIV/AIDS research has saved millions of lives globally and led to innovative advances in multiple diseases. Fred Hutch Cancer Center
• 27 Oct: EXCLUSIVE: EU mulls copying US with end to aid for global health funds. Euroactiv
• 27 Oct: Zambia launches malaria vaccine to protect over half million children. Gavi
• 27 Oct: Gavi is leaping into the future: there is no time to lose. Gavi
• 27 Oct: The Guardian view on global aid cuts: a malaria resurgence could be the canary in the coalmine. The Guardian
• 27 Oct: SA becomes the first African country to register the twice-a-year anti-HIV jab — at record speed. Bhekisisa
• 28 Oct: Seth Berkley interview: vaccination in a time of extreme scepticism. BMJ
• 28 Oct: Lenacapavir Regulatory Approval. AVAC
• 28 Oct: Establishing the world’s largest Nipah virus vaccine reserve. CEPI
• 28 Oct: To end TB, time for us to own our disease response and financing for health. Devex
• 28 Oct: WHO Member States Get Skeleton Draft on Pathogen Sharing Ahead of Text-Based Negotiations. Health Policy Watch
• 28 Oct: Transforming HIV Prevention in 2025. AVAC
• 29 Oct: A ‘devil’s choice’ on vaccines and pandemic preparedness. STAT
• 29 Oct: The bat paradox: what nature’s night flyers could teach us about pandemics – and ourselves. Gavi
• 29 Oct: ‘The Great Mimicker’: meet the deadly bacterium spreading worldwide. Gavi
• 29 Oct: Possible EU cuts to HIV and vaccine funding ‘irresponsible’, Global Fund says. Euractiv
• 29 Oct: Global vaccine safety network to launch in six countries across three continents. CEPI
• 30 Oct: How will the new malaria vaccine shape Africa’s economic future?. UK Government
• 30 Oct: Innovations in Sexual and Reproductive Health. The Lancet
• 30 Oct: Access Strategy for Lenacapavir for PrEP in Low- and Middle-Income Countries. Gilead
• 30 Oct: How Moderna, the company that helped save the world, unraveled. STAT
• 31 Oct: Working to Make Africa Attractive for Global Clinical Trials. Health Policy Watch
Upcoming Meetings/ Webinars
--------------------------